Ali Asif
Reporting owner on Forms 3, 4 and 5, CIK 1921163.
Ali Asif reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Protagonist Therapeutics, Inc CIK 1377121 | officer (Chief Financial Officer) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics, I… Common Stock | 2026-09-30 | M exercised | +9,229 | $38.98 | 68,232 | Form 4 |
| Protagonist Therapeutics, I… Common Stock | 2026-09-30 | M exercised | +28,438 | $23.42 | 96,670 | Form 4 |
| Protagonist Therapeutics, I… Common Stock | 2026-09-30 | M exercised | +15,650 | $19.19 | 112,320 | Form 4 |
| Protagonist Therapeutics, I… Common Stock | 2026-09-30 | M exercised | +5,312 | $12.17 | 117,632 | Form 4 |
| Protagonist Therapeutics, I… Common Stock | 2026-09-30 | S sold | -12,595 | $141.77 | 105,037 | Form 4 |
| Protagonist Therapeutics, I… Common Stock | 2026-09-30 | S sold | -46,034 | $141.78 | 59,003 | Form 4 |
| Protagonist Therapeutics, I… Stock Option (right to buy), derivative | 2026-09-30 | M exercised | -9,229 | $0 | 29,291 | Form 4 |
| Protagonist Therapeutics, I… Stock Option (right to buy), derivative | 2026-09-30 | M exercised | -28,438 | $0 | 49,562 | Form 4 |
| Protagonist Therapeutics, I… Stock Option (right to buy), derivative | 2026-09-30 | M exercised | -15,650 | $0 | 51,150 | Form 4 |
| Protagonist Therapeutics, I… Stock Option (right to buy), derivative | 2026-09-30 | M exercised | -5,312 | $0 | 25,235 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001104659-26-113279 | Protagonist Therapeutics, Inc | 2026-10-02 |